TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T01012 XX ID T01012 XX DT 31.01.1994 (created); ewi. DT 19.11.2007 (updated); djp. CO Copyright (C), QIAGEN. XX FA MEF-2B1 XX SY MEF-2B; MEF-2B-1; RSRFR2; xMEF-2; xMEF2. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G116926 MEF2B; HGNC: MEF2B. XX CL C0014; MADS; 5.1.1.1.2. XX SF xMEF-2 and RSRFR2 are identical, but arise from differentially spliced transcripts that differ in their 5'-UTR [1] [2]; SF its DNA-binding capability to MEF-2-sites is inhibited by C-terminal sequences [2]; XX CP ubiquitous, particular high levels in B cells [2]; skeletal muscle, brain, placenta, (lung) [1] [1] [2]. CN liver, kidney [1]. XX FF presumably by heterodimerization with a DNA-binding component, xMEF-2 can act as a potent transcriptional activator [1]; XX IN T01012 MEF-2B1; human, Homo sapiens. IN T01785 MEF-2B1; mouse, Mus musculus. IN T01009 RSRFC4; human, Homo sapiens. XX MX M07424 V$MEF2_Q6_03. XX BS R09147. XX DR TRANSPATH: MO000025340. DR UniProtKB: Q02080; XX RN [1]; RE0000768. RX PUBMED: 1516833. RA Yu Y.-T., Breitbart R. E., Smoot L. B., Lee Y., Mahdavi V., Nadal-Ginard B. RT Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors RL Genes Dev. 6:1783-1798 (1992). RN [2]; RE0000769. RX PUBMED: 1748287. RA Pollock R., Treisman R. RT Human SRF-related proteins: DNA-binding properties and potential regulatory targets RL Genes Dev. 5:2327-2341 (1991). XX //